Advanced glycation end products increase collagen-specific chaperone protein in mouse diabetic nephropathy.
about
Transforming growth factor-beta induces cellular injury in experimental diabetic neuropathyMolecular targets for diabetes mellitus-associated erectile dysfunction.Activation of bone morphogenetic protein 4 signaling leads to glomerulosclerosis that mimics diabetic nephropathyAdvanced glycation end-products induce connective tissue growth factor-mediated renal fibrosis predominantly through transforming growth factor beta-independent pathway.Emerging drugs for diabetic nephropathy.Blockade of advanced glycation end product formation attenuates bleomycin-induced pulmonary fibrosis in rats.Increased AGE-RAGE ratio in idiopathic pulmonary fibrosis.A survey and analysis of the role of molecular chaperone proteins and imidazole-containing dipeptide-based compounds as molecular escorts into the skin during stress, injury, water structuring and other types of cutaneous pathophysiology.SOX9 protein induces a chondrogenic phenotype of mesangial cells and contributes to advanced diabetic nephropathy.Heat shock proteins and kidney disease: perspectives of HSP therapy.Adjusting the 17β-Estradiol-to-Androgen Ratio Ameliorates Diabetic Nephropathy.Preventive Effect of Salicylate and Pyridoxamine on Diabetic Nephropathy.Overhydroxylation of Lysine of Collagen Increases Uterine Fibroids Proliferation: Roles of Lysyl Hydroxylases, Lysyl Oxidases, and Matrix Metalloproteinases.Heat Shock Proteins in Vascular Diabetic Complications: Review and Future Perspective.Aliskiren attenuates bleomycin-induced pulmonary fibrosis in rats: focus on oxidative stress, advanced glycation end products, and matrix metalloproteinase-9.Effect of heat shock protein 47 on collagen synthesis of keloid in vivo.
P2860
Q28575618-0AC57551-4C16-4F18-82D4-405B21598D80Q33770111-6B2C08F0-D091-432A-869C-800EA75CE3ACQ35011158-C385FB9D-8E10-4BE4-BC26-AB2A9E336AE5Q35103591-6CC2F8E2-30F5-4BDF-902D-4FB510D9CB95Q36302838-897EC656-1B90-49B7-9AD8-CAE765E2EC44Q37266352-F2DDD5B2-2674-4FCF-909B-17CB9353BBD7Q37396756-05110B52-AC0A-432C-BE74-ACF180001821Q37764922-6B9594B6-DAE2-48D8-8416-23AD3886AE46Q38420802-8985FEFD-1DC7-490E-AB6A-9BE048945DFBQ39242393-CE26C02D-F32E-4F85-9A3E-514BB1C6433BQ41645541-31076B2C-ADDD-4249-9E8A-608734460D87Q42157259-49CF1CD3-5386-40CA-9DCA-A8EE672BC350Q42730647-D3AD6CCE-3512-4778-83DE-70AC38948213Q47294278-B11ED050-D6D4-4C07-8EA3-B1243BACD2D5Q53763737-A0E8FBEA-5111-4B63-A6CD-ED99769B931EQ54326311-BDC888CB-2361-459B-89DB-95FF44EC4873
P2860
Advanced glycation end products increase collagen-specific chaperone protein in mouse diabetic nephropathy.
description
2004 nî lūn-bûn
@nan
2004 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մարտին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Advanced glycation end product ...... in mouse diabetic nephropathy.
@ast
Advanced glycation end product ...... in mouse diabetic nephropathy.
@en
type
label
Advanced glycation end product ...... in mouse diabetic nephropathy.
@ast
Advanced glycation end product ...... in mouse diabetic nephropathy.
@en
prefLabel
Advanced glycation end product ...... in mouse diabetic nephropathy.
@ast
Advanced glycation end product ...... in mouse diabetic nephropathy.
@en
P2093
P2860
P356
P1476
Advanced glycation end product ...... in mouse diabetic nephropathy.
@en
P2093
Hideharu Abe
Hidenori Arai
Hiroshi Okamoto
Hiroshi Yamamoto
Kazuhiro Nagata
Masayoshi Takeuchi
Seiji Ohashi
Toshikazu Takahashi
Toshio Doi
P2860
P304
19816-19823
P356
10.1074/JBC.M310428200
P407
P577
2004-03-05T00:00:00Z